Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma of Skin AJCC V6”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03325101
What this trial is testing

Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+2 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00028431
What this trial is testing

Novel Adjuvants for Peptide-Based Melanoma Vaccines

Who this might be right for
Melanoma
University of Southern California 19
Testing effectiveness (Phase 2)Looking for participantsNCT05251389
What this trial is testing

FMT to Convert Response to Immunotherapy

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT00016263
What this trial is testing

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Genta Incorporated
Testing effectiveness (Phase 2)UnknownNCT02977052
What this trial is testing

Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma Stage III
The Netherlands Cancer Institute 186
Early research (Phase 1)Study completedNCT03590054
What this trial is testing

Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Stage III Cutaneous MelanomaStage IV Cutaneous MelanomaLocally Advanced Melanoma+18 more
Rahul Aggarwal 35
Not applicableActive Not RecruitingNCT03677739
What this trial is testing

Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+19 more
Rutgers, The State University of New Jersey 1,160
Testing effectiveness (Phase 2)Study completedNCT01676779
What this trial is testing

MRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Universitair Ziekenhuis Brussel 88
Testing effectiveness (Phase 2)Study completedNCT03554083
What this trial is testing

Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+3 more
Mayo Clinic 64
Early research (Phase 1)Study completedNCT00118313
What this trial is testing

Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Craig L Slingluff, Jr
Testing effectiveness (Phase 2)WithdrawnNCT00085579
What this trial is testing

Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06794775
What this trial is testing

SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma

Who this might be right for
Malignant Melanoma Stage III
Hildur Helgadottir 128
Testing effectiveness (Phase 2)Study completedNCT01973322
What this trial is testing

Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study

Who this might be right for
Malignant Melanoma of Skin Stage IIIMalignant Melanoma of Skin Stage IV
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 34
Large-scale testing (Phase 3)Active Not RecruitingNCT02506153
What this trial is testing

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+6 more
National Cancer Institute (NCI) 1,301
Large-scale testing (Phase 3)Active Not RecruitingNCT00003641
What this trial is testing

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

Who this might be right for
Melanoma (Skin)
ECOG-ACRIN Cancer Research Group 1,150
Early research (Phase 1)Active Not RecruitingNCT03161431
What this trial is testing

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Syntrix Biosystems, Inc. 77
Early research (Phase 1)Ended earlyNCT01409174
What this trial is testing

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 19
Not applicableUnknownNCT05402059
What this trial is testing

Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

Who this might be right for
MelanomaMelanoma (Skin)Melanoma, Uveal+5 more
MelanomaPRO, Russia 1,570
Testing effectiveness (Phase 2)UnknownNCT00811759
What this trial is testing

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Gustave Roussy, Cancer Campus, Grand Paris 58
Testing effectiveness (Phase 2)Study completedNCT00118274
What this trial is testing

Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Craig L Slingluff, Jr 170
Next Page